Quality of life in patients with lung cancer

Julia DiGiovanni, Marko Popovic, Edward Chow*, David Cella, Jennifer L. Beaumont, Jasmine Nguyen, Dominic Chu, Anthony Adili, Natalie Pulenzas, Breanne Lechner, Henry Lam, Andrew Bottomley

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations


In this chapter we compare the development, characteristics, validity and reliability of two widely used quality of life (QOL) assessment tools in lung cancer: the EORTC QLQLC13 and the FACT-L. The authors found that both questionnaires were developed from input of patients and health care professionals. The QLQ-LC13 is a 13-item instrument that assesses coughing, hemoptysis, dyspnea and pain and the side effects of treatment. Two international field studies have concluded that the QLQ-LC13 is clinically valid and useful. Conversely, the FACT-L assesses general QOL and seven lung cancer-specific items, such as shortness of breath, weight loss, cough, and appetite. In a study of 116 lung cancer patients, the FACT-L was found to have a good internal consistency, reliability, and sensitivity to changes in performance status. Ultimately, both the EORTC QLQ-LC13 and the FACT-L have been sufficiently validated; as such, decision-making should depend on the needs of the investigation.

Original languageEnglish (US)
Title of host publicationCancer
Subtitle of host publicationTreatment, Decision Making and Quality of Life
PublisherNova Science Publishers, Inc.
Number of pages14
ISBN (Electronic)9781634838825
ISBN (Print)9781634838634
StatePublished - Jan 1 2016

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Quality of life in patients with lung cancer'. Together they form a unique fingerprint.

Cite this